Dr Carl-Johan Spak

Member of the Board of Directors on behalf of Flerie Invest

Carl-Johan is a member of the Board of Directors of Prokarium and was its CEO until Ted Fjallman took over in 2014. He graduated with a doctorate in dental surgery in 1980 and a PhD in pharmacology from the Karolinska institute in 1984. He has since held a number of positions in medical and pharma companies and currently serves as director of several technology development companies. Carl-Johan is Executive VP Development & Technology at Recipharm AB and executive director of Cobra Biologics Ltd.